Filter
324
Filtered Results: 324
Text search:
mRNA
Featured
Recommendations
62
New Publications
9
Language
Document type
Guidelines
103
Fact sheets
65
Studies & Reports
42
No document type
37
Videos
29
Manuals
13
Resource Platforms
11
Strategic & Response Plan
9
Training Material
5
Infographics
5
Situation Updates
3
Brochures
1
Online Courses
1
Countries / Regions
Germany
23
Brazil
17
Russia
12
Global
11
Ukraine
9
Latin America and the Carribbean
9
Middle East and North Africa
7
India
7
South Africa
5
Ecuador
5
Syria
4
Nigeria
4
Argentina
4
Yemen
4
Senegal
3
Mozambique
3
Africa
3
Lebanon
3
Eastern Europe
3
China
2
Kazakhstan
2
Chile
2
Niger
2
Peru
2
Haiti
2
Western and Central Europe
2
Belarus
2
Uganda
2
Sudan
2
Mali
2
South Sudan
2
Somalia
2
Colombia
1
Kenya
1
Mexico
1
El Salvador
1
Benin
1
Sierra Leone
1
Rwanda
1
Cameroon
1
Congo-Brazzaville
1
Burkina Faso
1
Morocco
1
Qatar
1
Mauritania
1
Dominican Republic
1
Venezuela
1
Jordan
1
Saudi Arabia
1
Congo, Democratic Republic of
1
West and Central Africa
1
South–East Asia Region
1
Paraguay
1
France
1
Tunisia
1
United Kingdom
1
Spain
1
Israel
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Nicaragua
1
Egypt
1
Ethiopia
1
Honduras
1
Angola
1
Chad
1
Libya
1
Indonesia
1
Iraq
1
Liberia
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
COVID-19
85
Guidelines
35
Information, Education and Communication (IEC)
16
Policies
6
x MEDBOX Issue Brief & Annual Reports x
5
Cervical Cancer
5
Vaccine-preventable Diseases
5
Studies & Reports
5
Policies & Guidelines HIV & TB
4
Communicable Diseases
3
Capacity Building
3
TB
3
Cancer
2
Infection Control & Prevention (IPC)
2
Pediatrics
2
Humanitarian Crisis
2
Immunization
2
Health Systems
2
HIV & STI
2
Disease Prevention & Control
2
Hepatitis
1
Pharmacy & Technology
1
Disaster Preparedness
1
General Guidelines
1
MPOX - Monkeypox
1
Virology
1
Countries
1
Medical Devices & Equipment
1
Yellow Fever
1
Women & Child Health
1
Statistics
1
Communicable Diseases
1
Gynaecology & Obstetrics
1
Non-communicable Diseases
1
Malaria
1
Reproductive Health
1
Pharmacy & Technologies
1
Toolboxes
COVID-19 Vaccination Information
35
Country specific documents
33
Videos
32
Communication Material
30
Vaccine Hesitancy & Myths
26
Immunization Guidelines
24
COVID-19 Vaccination
23
Biontech/Pfizer Comirnaty
21
Access & Strategy
15
For Migrants & Refugees
13
Infection Control General
12
For General Public & Community
12
mRna Vaccines general
11
Moderna
11
Logistics & Supply
10
Inactivated COVID-19 Vaccines
10
Clinical Guidelines
9
SARS-CoV-2 Variants
9
Vector-based Vacines General
9
Booster Doses
9
Fair Allocation & Ethical Aspects
8
Vaxzevria (Astra Zeneca)
7
Surveillance & Contact tracing
6
COVID-19 Information
6
Dashboards & Resource Platforms
6
Research & Pipeline
6
Vaccination
5
For Health Worker
5
Vaccine Candidates & Research
5
Anamnesis / Screening
4
Training, others
4
For Older People
4
Scientific & Research Studies
4
Blood Supply
4
Guidelines & Manuals
4
Prevention & Preparedness
3
Poster & Infographics
3
For Pregnant Women
3
Global Impact: Socio-economic, health services, TB & HIV
3
Educational Settings
3
Workplace
3
Physical Distancing
3
Mythbusters/Misinformation
3
COVAX Initiative
3
Information Refugees Ukraine
3
COVID-19
3
Male Circumcision
2
General Reports
2
Vaccines & Immunization
2
PPE Personel Protective Equipment
2
Treatment Guidelines
2
Diagnostics & Laboratory Guidance
2
For Parents & Children
2
Information for the Public
2
HIV and COVID-19
2
Tips & Best Practice Examples
2
Vaccination & Strategy
2
Long COVID/ Post-COVID Syndrome
2
Johnson & Johnson
2
Covaxin
2
Pharmacovigilance
2
Situation Reports & Updates
2
General
2
Education material
2
Health Financing Toolbox
2
Drug resistant TB
2
Research & Access
2
Neurological disorders, Others
2
Gynaecology / Obstetrics
1
Laboratory Guidance
1
Agriculture & Veterinary
1
Clinical Aspects, Treatment & Prevention
1
Europe
1
Treatment & Prevention
1
Clinical Aspects
1
Influenza Prevention & Control
1
Diagnosis & Treatment PTSD in Children
1
Pediatrics
1
Information for Refugees & Migrants
1
Neuropsychology of Trauma
1
Hepatitis
1
Public Health
1
HIV
1
TB
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Children/Adolescents Mental Disorders
1
Clinical aspects
1
Mental Health Guidelines
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Context & Facts, Travel Advice
1
Online Courses & Resources
1
COVID-19
1
Public Health
1
PPE Personel Protective Equipment
1
Video & Audio
1
For People with Disabilities
1
Appeals and Response Plans
1
Dashboards & Maps
1
Resource Platforms others
1
Gender Aspects
1
Paediatrics
1
COVID-19
1
Hospital Readiness/Essential Health Services
1
Non-pharmaceutical interventions (NPIs)
1
Long-term Care Facilities
1
TB/HIV
1
Genomic sequencing
1
TB/COVID-19
1
Sputnik V
1
Chile
1
Essential Medicines
1
Prices and Patents
1
Pharmacy Practice
1
Supply Chain & Store Management
1
Rational use of Medicine
1
Traditional & Herbal Medicines
1
General Guidelines for Rational Use
1
Ukraine
1
Zoonoses
1
MPOX - Monkeypox
1
MPOX - Monkeypox
1
MPOX -Monkeybox Prevention & Control
1
Strategies & Roadmaps
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Dracunculiasis (guinea-worm disease)
1
General Information
1
Prevention & Strategies
1
Studies & Reports
1
Studies & Reports
1
Women
1
Global Overview
1
Detection & Diagnosis
1
Co-Morbidities (except TB)
1
Human Rights & the Right to Health
1
Nutrition
1
Technical Information
1
TB/HIV Coinfection
1
Clinical Guidelines
1
Anxiety Disorders
1
Global Health Institutions and Stakeholders
1
Antiretroviral Treatment ART
1
TB
1
War, Conflict Areas & Refugees
1
Depression
1
Studies & Reports
1
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
Weekly epidemiological update on COVID-19, 28 September 2022
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Contact tracing and quarantine in the context of COVID-19: interim guidance, 6 July 2022
recommended
Contact tracing for COVID-19 is the process of identifying, assessing, and managing people who have been exposed to someone who has been infected with the SARS-CoV-2 virus, while quarantine is the separation of contacts from other people after exposure to a probable or confirmed case of SARS-CoV-2 i...
This document provides guidance on interventions to prevent vaccine-preventable disease outbreaks in the context of mass population movement resulting from the ongoing crisis in Ukraine.
This policy brief draws from the latest evidence on the impact of vaccination program start date and vaccine rollout rates on health benefits. The objective is to support policymakers on decisions to procure COVID-19 vaccines and roll out vaccination programmes in countries, especially those
where ...
Cette note politique s’appuie sur les données les plus récentes concernant l’impact de la date de début du programme de vaccination et des taux de déploiement des vaccins sur les bénéfices pour la santé. L’objectif est de soutenir les décideurs politiques dans leurs décisions d’appr...
Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended
Cases of human monkeypox are rarely seen outside of west and central Africa. There are few data regarding viral kinetics or the duration of viral shedding and no licensed treatments. Two oral drugs, brincidofovir and tecovirimat, have been approved for treatment of smallpox and have demonstrated eff...
As vacinas COVID-19 são eficazes contra novas variantes? O que significa para uma pessoa estar totalmente vacinada? Essa e outras dúvidas estão entre as dúvidas mais frequentes sobre a vacinação contra a COVID-19. Nesta sexta edição você encontrará respostas para essas e outras perguntas.
...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
first issued 18 August 2022
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
The Pandemic Influenza Preparedness (PIP) Framework is a World Health Assembly resolution adopted unanimously by all Member States in 2011. It brings together Member States, industry, other stakeholders and WHO to implement a global approach to pandemic influenza preparedness and response. The Frame...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
